Your browser doesn't support javascript.
loading
Long-term outcomes in patients with advanced and/or metastatic non-small cell lung cancer who completed 2 years of immune checkpoint inhibitors or achieved a durable response after discontinuation without disease progression: Multicenter, real-world data (KCSG LU20-11).
Kim, Hongsik; Kim, Dong-Wan; Kim, Miso; Lee, Youngjoo; Ahn, Hee Kyung; Cho, Jang Ho; Kim, Il Hwan; Lee, Yun-Gyoo; Shin, Seong-Hoon; Park, Song Ee; Jung, Jiyoon; Kang, Eun Joo; Ahn, Myung-Ju.
Afiliación
  • Kim H; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Kim DW; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Kim M; Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Hospital, Seoul, Republic of Korea.
  • Lee Y; Division of Hematology-Oncology, Department of Medicine, National Cancer Center, Goyang, Republic of Korea.
  • Ahn HK; Division of Medical Oncology, Department of Internal Medicine, Gachon University Gil Medical Center, Incheon, Republic of Korea.
  • Cho JH; Division of Oncology, Department of Internal Medicine, Incheon St. Mary's Hospital, Catholic University of Korea, Incheon, Republic of Korea.
  • Kim IH; Division of Oncology, Department of Internal Medicine, Inje University College of Medicine, Haeundae-Paik Hospital, Busan, Korea.
  • Lee YG; Division of Hematology-Oncology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Shin SH; Division of Hematology-Oncology, Department of Medicine, Kosin University Gospel Hospital, Busan, Republic of Korea.
  • Park SE; Division of Hematology-Oncology, Department of Internal Medicine, Chung-Ang University College of Medicine, Seoul, Korea.
  • Jung J; Division of Hematology-Oncology, Department of Internal Medicine, Yeungnam University Medical Center, Daegu, Republic of Korea.
  • Kang EJ; Division of Hemato-Oncology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Republic of Korea.
  • Ahn MJ; Division of Hematology-Oncology, Department of Internal Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
Cancer ; 128(4): 778-787, 2022 Feb 15.
Article en En | MEDLINE | ID: mdl-34705268
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Observational_studies Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article